Universal ART could reduce HIV prevalence from 40 million to 1 million by 2050, Canadian researchers claim

The authors, led by Professor Julio Montaner, say their model shows that HIV prevalence could be reduced
70-fold, from 7 cases per 1000 people to 0.1 case per 1000 by 2050.

READ THE ARTICLE

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025